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Mycobacteria display pro- and anti-inflammatory effects in human and experimental 
pathology. We show here that both effects are mediated by Toll-like receptor 2 (Tlr2), 
by exploiting a previously characterized Tlr2 variant (Met82Ile). Tlr2 82ile promoted 
 self-specific proinflammatory polarization as well as expansion of ag-specific FoxP3+ 
Tregs, while Tlr2 82met impairs the expansion of Tregs and reduces the production 
of IFN-γ and IL-17 proinflammatory cytokines. Preferential dimerization with Tlr1 or 
Tlr6 could not explain these differences. In silico, we showed that Tlr2 variant Met82Ile 
modified the binding pocket for peptidoglycans and participated directly to a putative 
binding pocket for sugars and cadherins. The distinct pro- and anti-inflammatory actions 
impacted severity, extent of remission, and distribution of the lesions within the central 
nervous system of experimental autoimmune encephalomyelitis. Thus, Tlr2 has a janus 
function in vivo as mediator of the role of bacterial products in balancing pro- and anti-in-
flammatory immune responses.
Keywords: Tlr2, eae/Ms, host–pathogen interactions, inflammation, Foxp3
inTrODUcTiOn
The administration of adjuvants containing Mycobacterium tuberculosis (Mtb)-derived products that 
interact with pathogen-recognition receptors (PRRs) at the moment of antigen challenge is essential 
for the development of optimal allo- (1) and self-reactive immune responses (2–4). Yet, the adminis-
tration of mycobacterium-derived products can promote or delay immunopathology, depending on 
disease type, timing of administration, and possibly genetic factors. Likewise, environment-derived 
agents contribute to the determination of autoimmune diseases, such as multiple sclerosis (MS), 
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influencing the variability of clinical course and severity (5–9). 
In particular, the role of bacterial infections in modulating MS 
course is well established (10, 11), and it has been demonstrated 
that BCG administration (in human) or complete Freund’s 
adjuvant (CFA) (in mouse) is beneficial for the treatment of 
MS, delays the development of type I diabetes, and interferes 
with the development of allergy (12–18). Thus, products derived 
from mycobacteria have a janus role, being able to promote or 
downmodulate proinflammatory immune responses.
Pathogen-recognition receptors expressed by the distinct 
subsets of DC play a major role in determining the outcome of 
immune responses to pathogens, by regulating the secretion of 
directive cytokines (19). Among PRRs, Tlr2 is the main innate 
receptor recognizing products from Mtb, and it has the widest 
repertoire of ligands, co-acting with a variety of other molecules. 
Its main binding pocket for lipopeptides (and the selective syn-
thetic ligands Pam2CSK4 and Pam3CSK4) lies between residue 
286 and residue 366. No evidences have been reported about (a) 
different binding site(s) for those large, repetitive, and hydrophilic 
molecules that are also able to stimulate it.
Tlr2 regulates the secretion of directive cytokines, expression 
of costimulatory molecules and cell mobility. Tlr2 is expressed 
in many immune cell types, including antigen-activated T cells 
(20). Several authors have reported that Tlr2 contributes to the 
polarization toward proinflammatory phenotypes of T cells and 
controls Treg development (21–25) and function in vitro, increas-
ing or decreasing it depending on the ligands used (26–28). 
However, it is not clear whether the opposite immunomodulatory 
effects of mycobacteria products can be mediated by Tlr2 also 
in vivo.
Tlr2 KO mice abrogate at the same time all signals coming from 
any Tlr2 dimer; since dimers of Tlr2 with distinct co-receptors 
may play different or even opposite roles in the development 
of the immune response when complex adjuvant, such as Mtb, 
is used, KO mice possibly do not represent a suitable model to 
assess the role of Tlr2 in vivo. Accordingly, it is not surprising 
that Tlr2 KO mice have provided conflicting evidences about its 
role in vivo, in EAE. In addition, genetic evidences show that also 
Tlr4 and Tlr9 are involved in the protection from Mtb, and Tlr4 is 
the second receptor for Mtb-derived motives (29). Thus, it is also 
possible that pro- and anti-inflammatory effects of Mtb may be 
mediated by distinct Tlrs.
We have previously shown that a single non-synonymous 
nucleotide polymorphism (SNP) exists between Tlr2 of SJL and 
B6 strains (generating a polymorphism Ile82Met, respectively). 
This polymorphism affects the sensitivity to the amount of Mtb 
in the adjuvant, leading to differences in the mobilization of 
activated T cells from the lymph nodes (LNs). Tlr282met displays 
a dominant ability over Tlr282ile to promote early exit of antigen-
specific T cells in the presence of limiting amounts of Mtb (30). 
While Tlr2 expressed on the APCs mediates most effects of the 
engagement of Tlr2 on the immune response, it is the engage-
ment of Tlr2 expressed by the activated T cells that determines 
the early/late mobilization from LNs (30).
Our model based on a Tlr2 polymorphism allows to examine 
the role of Tlr2 in F1 (SJL × B6wt) mice having Tlr2 of both SJL 
(Tlr282ile) and B6 (Tlr282met), with Tlr282met dominant, as well as 
F1 [SJL × B6129TLR2tm 1 kir/3(B6Tlr2−)] mice displaying only Tlr282ile of 
SJL origin (30). We have previously shown that the two F1 mice 
express similar Tlr2 levels on immune cells, despite having a dif-
ferent gene dosage. This model is less intrusive than a KO model 
and allows defining as Tlr2-dependent those functions that are 
differentially expressed in vivo in the above described F1 mice, 
leaving Tlr2 intact.
Notably, both parental strains SJL and B6 develop EAE, but 
with distinct clinical courses (31, 32), suggesting that Tlr2 poly-
morphism may impact the disease development in these mice 
(33–36). Thus, this model is also a good candidate to define if 
and how Tlr2 represents a path for infectious agents to modulate 
pro- and anti-inflammatory autoimmunity.
We hereinafter report that Tlr2 haplotype regulates the secre-
tion of type 1/17 cytokines and Treg polarization. We found sig-
nificantly higher levels of basal and antigen-driven production of 
proinflammatory cytokines IFN-γ and IL-17 in F1 (SJL × B6Tlr2−) 
mice. Also, the level of mRNA specific for FoxP3 and the number 
of CD4+CD25+FoxP3+ cells was increased by antigen stimula-
tion in F1 (SJL × B6Tlr2−) mice, but not in F1 (SJL × B6wt) mice. 
Both pro- and anti-inflammatory effects of the polymorphism 
appeared due to the modification of the secretion of polarizing 
cytokines produced by the APCs. When we studied in silico, the 
effect of the polymorphism at position 82 on Tlr2, we observed 
that this residue is directly involved in a secondary pocket binding 
several sugars and cadherins, and influences the primary binding 
pocket of Tlr2. Furthermore, we found significant differences 
in the course and pathology of EAE in F1 (SJL ×  B6wt) vs. F1 
(SJL × B6Tlr2−) mice.
Thus, through the mediation of both pro- and anti-inflammatory 
effects of Mtb, Tlr2 is the molecular link between infectious his-
tory and autoimmune disease course, and a potential point of 
therapeutic intervention.
MaTerials anD MeThODs
ethics statement
This study was carried out in accordance with the recommenda-
tions of Ethic Committee for Animal Experimental of Università 
Cattolica del Sacro Cuore. All the experiments were performed 
in accordance with the experimental protocol sf 46373 (II25) 
approved by the Ethic Committee for Animal Experimental of 
Università Cattolica del Sacro Cuore.
Mice and Peptides
The 8- to 10-week-old SJL, C57Bl/6 (B6wt) mice and B6 129TLR2tm 1 
kir/3(B6Tlr2−) mice were purchased from Charles River (Calco, Italy) 
and kept in a conventional facility at the Catholic University of 
the Sacred Heart of Rome.
SJL and B6 mice were crossed to obtain F1 (SJL × B6wt) mice 
that have Tlr2 of both SJL and B6, whereas SJL and B6Tlr2− were 
crossed in order to obtain F1 (SJL × B6Tlr2−) mice that have only 
the copy of Tlr2 of SJL origin.
Tlr2 heterozygous F1 (SJL ×  B6Tlr2−) mice with one copy of 
Tlr2 of SJL origin, and Tlr2 homozygous F1 (SJL × B6ts) mice, 
with two copies of Tlr2 of SJL origin, were obtained by crossing 
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heterozygous (B6−/ts) mice with SJL mice, as previously described 
(21). Briefly, B6−/ts mice were obtained back-crossing F1 
(SJL × B6Tlr2−) mice to B6Tlr2− mice for nine further generations.
Peptide 139–151 (HSLGKWLGHPDKF) (p139) of the prote-
olipid protein was purchased from PRIMM (Milan, Italy) and was 
>95% pure, as determined by HPLC and mass spectroscopy.
The TLR2 agonists Pam2CSK4 (tlrl-pm2 s-1) and Pam3CSK4 
(tlrl-pms) were used at different concentrations, following the 
recommendations of the supplier (Invivogen, San Diego, CA, 
USA): for cell stimulation at 100 ng ml−1 and for immunization 
at 10 μg/mouse combined with incomplete Freund’s adjuvants 
(IFAs) as described below.
immunization
Mice were immunized subcutaneously (s.c.) with 50 μg/mouse 
of p139 in PBS emulsified 1:1 with enriched CFA IFA contain-
ing 4  mg/ml killed and heat-dried M. tuberculosis H37RA 
(Sigma-Aldrich, St. Louis, MO, USA) in a final volume of 100 μl/
mouse. Draining LNs were collected from mice 4 or 10 days after 
immunization. For cytokines and nuclear factors assessment, 
5 × 105 lymph node cells (LNC) per well were cultured in pres-
ence or absence of p139 10 μg/ml for 3 h in RPMI-1640 medium 
(Sigma-Aldrich, St. Louis, MO, USA) supplemented with 2 mM 
l-glutamine, 50 μM 2-ME, 50 μg/ml gentamicin (Sigma-Aldrich, 
St. Louis, MO, USA), and 0.2% mouse serum. LNC were resus-
pended in RLT buffer for RNA extraction. For flow cytometry and 
for cytokines production assessment, LNC were cultured for 18 h 
at the same conditions described above.
Microarray analysis
Total RNA Extraction
Total RNA was extracted from six samples [three F1 (SJL × B6wt) 
and three F1 (SJL × B6Tlr2−) mice] in total using TRIZOL® reagent 
(Life Technologies Inc., Carlsbad, CA, USA) and then purified 
with RNeasy Micro columns (Qiagen, Venlo, Netherlands), as 
described by the manufacturers. The quality of all samples was 
strictly controlled to verify the RNA integrity before use in micro-
array experiments. RNA quantity and purity were evaluated 
spectrophotometrically by Nanodrop 1000 (Thermo Scientific, 
Waltham, MA, USA) and then by Quant-iT™ Ribogreen® RNA 
Assay kit (Invitrogen, Waltham, MA, USA), while the quality 
was assessed by the Agilent 2100 bioanalyzer RNA Pico 6000 kit 
(Agilent Technologies, Inc., Santa Clara, CA, USA). Only samples 
with good RNA yield and no RNA degradation (28S:18S >1.7 and 
RNA integrity number >6) were retained for further experiments.
Gene Expression Microarray
One hundred nanograms of each total RNA was processed using 
the Ambion® WT Expression kit (Life Technologies, Waltham, 
MA, USA) with T7-Oligo(dT) Primers, adding in the mix 2 μl of 
poly-A RNA controls (lys, phe, thr, and dap). These controls were 
amplified and labeled together with the total RNA sample. The 
10 μg of cRNA were input into the second cycle cDNA (ss-cDNA) 
reaction, and then, 5.5 μg of ss-cDNA were input for fragmenta-
tion, using the GeneChip® WT Terminal Labeling kit (Affymetrix, 
Santa Clara, CA, USA). Each cDNA fragment was end labeled with 
biotin using terminal deoxynucleotidyl transferase (37) before 
being hybridized to the arrays and, finally, was added to a hybridi-
zation cocktail (50-pM control oligonucleotide B2; 15, 5, 25, and 
100 pM, respectively, of BioB, BioC, BioD, and cre hybridization 
controls; 1× hybridization mix; 10% DMSO; nuclease-free water): 
this mixture was heated to 99°C for 5 min and to 45°C for another 
5 min. Then, it was injected into Affymetrix Mouse Exon 1.0 ST 
microarray chips (Affymetrix, Santa Clara, CA, USA), and the 
hybridization was performed under rotation at 45°C ± 16 h. The 
GeneChip® Mouse Exon 1.0 ST Array is a single array with over 
4.5 million unique 25-mer oligonucleotide features constituting 
approximately 1.2 million probe sets. For the gene-level analysis, 
the chip contains about 23339 probe sets.
After hybridization, the arrays were washed and stained 
with R-phycoerythrin streptavidin in the GeneChip® Fluidics 
Station 450 and then were scanned with the GeneScanner 3000 
System. Affymetrix GeneChip® Command Console (AGCC) and 
Expression Console software were used for washing, scanning, 
and basic analysis of the arrays that produced .CEL intensity files. 
Following scanning, array images were assessed by eye to confirm 
scanner alignment and the absence of significant bubbles or 
scratches. BioB spike controls were found to be present on 100%, 
with BioC, BioD, and CreX also present in increasing intensity. 
Moreover, the hybridization intensities of poly-A controls helped 
to monitor the labeling process, independently from the quality 
of the starting RNA samples.
Bioinformatics Analysis
The following analysis steps were performed using Partek Genomic 
Suite 6.6 (Partek Inc., St. Louis, MO, USA) and Transcriptome 
Analysis Console (TAC) 3.0 (Affymetrix) software. Three quality 
checks were performed to verify the quality of sample preparation 
and hybridization.
The pos_vs_neg_AUC value: this is the area under the curve 
(AUC) for a receiver operating characteristic (ROC) plot compar-
ing the signal values for positive controls with those for negative 
controls. The ROC curve is generated by evaluating how well the 
probe set signals separate the positive controls from the negative 
ones with the assumption that the negative ones are a measure 
of false positives and the positive controls are a measure of true 
positives. An AUC of 1 reflects perfect separation, whereas an 
AUC value of 0.5 would reflect no separation. Values between 
0.80 and 0.90 are typical.
The principal component analysis (PCA) for all samples was 
used to verify the distributions of the replicates: this multivariate 
technique allows reduction of the high dimensionality of genes 
space. In this way, samples and genes can be represented in mul-
tiple bidimensional spaces, and plotted to visually assess simi-
larities and differences between samples and determine whether 
samples can be grouped. Outlier samples should be identified and 
eliminated. This is particularly true in analysis of exon array data 
since low sample quality is likely to be highly influential in gen-
erating noise, therefore leading to high false positive rates (38). 
Hierarchical clustering based on complete linkage method and 
Pearson correlation as similarity measure was applied to evaluate 
the effect of the different sources of variability (sample and host 
specific responses). The resulting dendogram can be interpreted 
similarly to a phylogenetic tree.
FigUre 1 | Microarray analysis indicates that Tlr2 genotype modulates immune-related pathways. Three F1 (SJL × B6wt) and three F1 (SJL × B6Tlr2−) were 
immunized s.c. with CFA as described. The mice were sacrificed at day 4 after immunization. Heat map showing different expression patterns of the most significant 
regulated genes, selected with a fold change <1.5 and >1.5 and a p-value of 0.05 in the F1 (SJL × B6Tlr2−) and F1 (SJL × B6wt) samples. The heat map indicates 
upregulation (red), downregulation (green), and mean gene expression (black). The columns represent individual samples, while the rows represent the genes. A total 
of 23339 genes in gene-level analysis were tested.
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After these quality checks, based on PCA shown in Figure 1, 
six samples (three samples for condition) were used for the final 
analysis. Affymetrix Expression Console was used to process the 
original .CEL files and generate .chp files using the RMA-sketch 
workflow after signal summarization (median polish) (39) and 
data normalization (sketch-quantile method).
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A gene-level analysis was performed by TAC software: a total 
of 23339 genes were tested to compare their expression between 
3 F1 (SJL × B6Tlr2−) samples and 3 F1 (SJL × B6wt) samples. The 
analysis of variance (ANOVA) was used for the detection of dif-
ferentially expressed genes (DEGs). Only the probe sets whose 
fold changes were higher than or equal to 1.5 and p value of 0.05 
were selected as modulated.
Cytokine Production
Medium from cultures were collected and stained with 
MACSPlex Cytokine 10 Kit (Miltenyi Biotec, Bergisch Gladbach, 
Germany), following the manufacturer’s protocol. The samples 
were read using the Navios flow cytometer (Beckman Coulter, 
Pasadena, CA, USA) and analyzed with Kaluza Analysis 1.3 
software (Beckman Coulter, Pasadena, CA, USA). Samples were 
performed as duplicate.
Cytokine and Transcription Factors mRNA 
Measurement by Quantitative Real-Time PCR
Measurement of cytokines mRNA was performed on LN cells 
and infiltrating cells from the CNS. Total mRNA was isolated by 
RNeasy Mini Kit and cDNA was synthesized using an oligo-dT 
primer (dT15) according to the manufacturer’s instructions 
(Qiagen, Valencia, CA, USA). The optical density of extracted 
mRNA was determined at 260  nm using a NanoDrop 1000 
(Thermo Scientific, Waltham, MA, USA).
Quantitative RT-PCRs were performed with iQ™SYBR® 
Green Supermix and the iCycler instrument (Bio-Rad, Hercules, 
CA, USA). Relative expression levels of cytokine and transcrip-
tion factors mRNAs were normalized by 18S as a housekeeping 
gene and calculated by the 2−ΔΔCt method (40).
Primers sequences (Invitrogen™ Life Technologies, Paisley, 
UK) are listed in Table S2 in Supplementary Material in the 
5′–3′ orientation. Once the reaction conditions were settled, the 
samples were loaded as triple replicates.
Determination of CD4+CD25+FoxP3+ Cell
Lymph node cells from F1 (SJL × B6wt) and F1 (SJL × B6Tlr2−) were 
cultured as described above.
CD4+CD62Lhigh and CD4+CD62Llow T cells were enriched 
from the spleens of naive SJL using CD4+CD62L+ T Cell 
Isolation Kit II (Miltenyi Biotec, Bergisch Gladbach, Germany), 
according to the manufacturer’s instructions. Due to low yield, 
CD4+CD62Lhigh cells obtained from different mice of the same 
groups were pooled together. Cells were cultured for 6  h in 
medium (as described above) in presence or absence of 100 ng/ml 
of Pam2CSK4 or Pam3CSK4 (Invivogen®, San Diego, CA, USA), 
with or without Anti-biotin MACSBead Particles conjugated 
with αCD3ϵ + αCD28 (T cell Activation/Expansion kit MACS® 
Miltenyi Biotec, Bergisch Gladbach, Germany), following the 
manufacturer’s protocol. The same conditions were repeated 
in presence or absence of anti-galectine 9 (ab127982, dilution 
1:1000, rabbit polyclonal, Abcam, Cambridge, UK) at 0.1 μg/ml.
After harvesting, the cells were stained using the Treg 
Detection Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). 
The cells were tested using the Navios flow cytometer (Beckman 
Coulter, Pasadena, CA, USA) and analyzed with Kaluza Analysis 
1.3 software (Beckman Coulter, Pasadena, CA, USA).
Bioinformatics structural analysis
Ligand-Binding Analysis
Functional annotation of TLR2 was initially done using ligand-
binding site prediction based on COFACTOR algorithm (41).1 
The 3D structural model template-based ligand–protein dock-
ing uses consensus-based algorithm COACH for binding site 
prediction and the semi-manually curated database BioLiP for 
biologically relevant ligand–protein interactions, containing 
more than 204.223 entries, each having annotations on ligand-
binding residues, ligand-binding affinity, catalytic sites, Enzyme 
Commission numbers, Gene Ontology (GO) terms, and cross-
links to other databases.
Molecular Dynamics of Tlr2
A crystallography model of Tlr2 complexed with Tlr6 and hav-
ing a ligand Pam2CSK4 (PDB 3A79) was used for Tlr282ile as 
it was expressed to have the sequence found in the SJL strain. 
The I-Tasser server (42) for template-based modeling was used 
as best in class for homology combined with ab initio modeling 
to produce relevant initial structure for Tlr2 of B6 (where Met 
was substituted in place of Ile). Model preprocessing for missing 
H-bond addition and steric classes was done using the built-in 
algorithms of PDB2PQR and MDWeb. The ligand and other 
HETAMs were removed during this process. A complete setup for 
AMBER Parm99SB* forcefield (structure minimization, solvation 
with TIP3P water molecules, and 50-mM ions and equilibration 
using NPT ensemble with periodic boundary conditions) was 
made using MDWeb server (43).2 The equilibrated structural 
models were also used for an exploration of individual anisotropic 
normal mode localized perturbations, based on Protein Energy 
Landscape Exploration (PELE normal mode analysis) algorithm.3 
The latter combines a Monte Carlo stochastic approach with 
protein structure prediction (44).
Secondary Structure Analysis and Trajectory 
Analysis
The obtained results by PELE normal mode analysis trajectory 
were analyzed using Timeline plugin of VMD4 for following 
the temporally changing per-residue attributes of a molecular 
 structure such as RMSd and residue displacement (45). The 
H-bonds were calculated per-frame using Chimera script in MD 
trajectory analysis module (46).
Ligand-Binding Interface Volume Analysis
Pam2CSK4 docked to Tlr282met or Tlr282ile was subject to ligand-
docked volume analysis using Chimera per-frame script as well as 
using MOLE2 algorithm for ligand-binding cavity detection (47). 
The obtained data were plotted in Excel.
1 http://zhanglab.ccmb.med.umich.edu/COFACTOR/
2 http://mmb.irbbarcelona.org/MDWeb/
3 https://pele.bsc.es
4 http://www.ks.uiuc.edu/Research/vmd/
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EAE Induction and Clinical Evaluation
The 8- to 10-week-old female mice were immunized s.c. with 
75  μg/mouse of p139 in PBS emulsified 1:1 in enriched CFA 
(100 μl/mouse). The 300  ng of Pertussis toxin (List Biological 
Laboratories, Inc., Campbell, CA, USA) were injected intraperi-
toneally on the day of immunization and 3  days later. Clinical 
signs of EAE were evaluated daily and in a blinded fashion 
according to the following scale: 0, no clinical score; 1, loss of tail 
tone; 2, weak hind leg paresis; 3, posterior leg paresis; 4, complete 
paraplegia; and 5, death (48, 49). Intermediate values were used 
for incomplete symptoms.
Mice at disease peak were perfused in PBS and sacrificed under 
deep anesthesia (ketamine 75 mg/kg and medetomidine 1 mg/kg 
i.p.). CNS-infiltrating cells were isolated by Percoll gradient and 
were resuspended in RLT buffer for RNA extraction.
CNS Histology
Mice, under deep anesthesia (ketamine 75 mg/kg and medeto-
midine 1 mg/kg i.p.), were sacrificed and perfused through the 
aorta with 50-ml saline solution, followed by 50 ml of 0.01M, 
pH 7.4 PBS, and 4% paraformaldehyde (VWR International, 
Radnor, PA, USA). Brains and spinal cords were removed and 
immersed in the same fixative for 24 h. The brains were cut into 
different blocks at three different levels along the rostro-caudal 
axis: frontal lobes, hippocampus/thalamus, and cerebellum/
brain stem, respectively, taken from the following bregma 
coordinates: from +2.22 mm to +0.38 mm, from −1.22 mm to 
−2.80 mm, and from −2.92 mm to −6.64 mm according to the 
atlas of Paxinos and Franklin (50) and then embedded in paraf-
fin. Serial 10-μm coronal sections from the brain and spinal cord 
were cut on a microtome and then processed for histological 
analysis (H&E) to assess for inflammatory lesions or immuno-
cytochemistry to reveal inflammatory cells (CD3-expressing 
lymphocytes and activated microglia), as previously described 
(4). Briefly, for CD3 labeling, sections were incubated overnight 
at +4°C with the primary Ab (rat monoclonal anti-CD3; BD 
Biosciences, Franklin Lakes, NJ, USA) and then for 1  h with 
a biotin-conjugated secondary Antibody (Vector Laboratories, 
Burlingame, CA, USA). Microglia cells were identified with the 
specific histochemical marker Ricinus Communis Agglutinin 
I (biotinylated Ricinus Communis Agglutinin 120; Vector 
Laboratories). Immunoreactive cells were visualized by the avi-
din–biotin immunoperoxide method with diaminobenzidine 
as chromogen (Vectastain Elite ABC Kit; Vector Laboratories, 
Burlingame, CA, USA).
Histological scores of infiltrates were assessed using a semi-
quantitative method, essentially as described also by other groups 
(51). Briefly, regularly spaced (every 100 μm) brain and spinal cord 
sections were analyzed with a brightfield microscope equipped 
with an AxioCam MRc and AxioVision software (Axiophot, 
Zeiss, Milan, Italy), at a magnification of 20×. Sections were 
photographed and blindly evaluated according to the following 
criteria: 0 = no inflammation; 1 = cellular infiltrates only around 
blood vessels and meninges; 2 =  moderate cellular infiltrates 
in parenchyma, less than 50% of the white matter (WM); and 
3 = severe infiltrates in parenchyma, deep and/or more than 50% 
of the WM.
Statistics
Statistics were performed with two-tailed Mann–Whitney test, 
one-way ANOVA with Bonferroni’s multiple comparison test, 
two-tailed Wilcoxon matched-pairs signed rank test, or χ2 test. 
p < 0.05 was considered significant (48, 49). Data were analyzed 
with GraphPad Prism 5.03 software (GraphPad Software, Inc., La 
Jolla, CA, USA).
resUlTs
Microarray analysis of ln cells shows 
That Tlr2 Polymorphism Modulates 
immune-related Pathways, Despite 
Overall remarkably similar responses
We have previously demonstrated a role for Tlr2 in T cell mobi-
lization in the presence of limiting amounts of Mtb in the adju-
vant. To further understand the impact of Tlr2 polymorphism 
on autoimmunity and inflammation, we compared global gene 
usage of enriched LN-derived T cells from F1 (SJL × B6Tlr2−) mice 
displaying only Tlr282ile of SJL origin, and F1 (SJL × B6wt) having 
Tlr2 of both SJL (Tlr282ile) and B6 (Tlr282met) strains, with Tlr282met 
dominant. We performed the comparison 4 days after challenging 
mice with CFA containing 50 μg/mouse of Mtb s.c., a time point 
at which we had shown that all primed antigen-specific T cells 
were still in the draining LN.
A total of 23339 genes were tested at core level to compare 
their expression between the two groups of F1 (SJL × B6Tlr2−) and 
F1 (SJL × B6wt) mice. As expected, due to high genetic homology 
between the F1 mice, 35 genes were found to be differentially 
expressed with absolute fold change >2 and ANOVA p-value 
<0.05 [one-way between-subject ANOVA (unpaired) method] 
and 125 genes with absolute fold change >1.5 and p-value <0.05 
(52). The heat map for the 125 genes is displayed in Figure 1.
To reveal global functional differences, the GO hierarchy 
analysis was then carried out on the DEGs. The genes were 
categorized according to the WikiPathways in TAC software. 
This software allowed selecting the principal pathways showing a 
modulation dependent on the Tlr2 haplotype (Table 1).
The most relevant pathways are lymphocytes signaling, 
cytokines, and inflammatory response-related pathways. It is of 
interest that also the pathway linked to spinal cord injury appears 
modulated by the polymorphism at position 82 of Tlr2.
Using this analysis, it was immediately noted that Tlr282ile 
[i.e., the response observed in F1 (SJL × B6Tlr2−) mice] is associ-
ated with a downmodulation of the pathways linked to type 2 
cytokines. The cytokines IL-10, IL-13, IL-5, and IL-2 were all 
significantly down regulated in F1 (SJL × B6Tlr2−) mice compared 
to F1 (SJL × B6wt) mice (Table S1 in Supplementary Material). 
Therefore, the transcriptomics data strongly suggested that 
the F1 (SJL × B6Tlr2−) mice display an aberrant deregulation of 
the T cells skewing pathways (Figure S1A in Supplementary 
Material). Additional analysis of the transcriptomics data for 
TaBle 1 | Principal pathways modulated in F1 (sJl × B6Tlr2−) compared to F1 (sJl × B6wt).
Pathway #Total #Up Up list #Down Down list
B cell receptor signaling pathway 11 0 11 Lyn, Syk, Blnk, Cr2, Cd19, Pik3ap1, Cd22, Fcgr2b, 
Cd72, Cd79a, Rasgrp3
XPodNet – protein–protein interactions in the 
podocyte expanded by STRING
5 0 Sh3bp1, Tspan7, 
Adam12
5 Cd19, Cd22, Blnk, Lyn, Slc4a1
IL-2 signaling pathway 4 0 4 Il2, Syk, Socs3, Lyn
Adipogenesis genes 4 1 Scd1 3 Socs3, Ebf1, Mef2c
IL-3 signaling pathway 4 0 4 Lyn, Syk, Socs3, Fcer2a
Cytokines and inflammatory response (BioCarta) 4 0 5 Il10, Il13, Il2, H2-Eb1
Odorant GPCRs 4 2 Gpr173, Tas2r138 2 Taar7d, Vmn2r1
Metapathway biotransformation 4 1 Cyp1a1 3 Cyp4f18, Chst3, Hs3st1
Spinal cord injury 3 3 Fcgr2b, Il2, Klk8
Chemokine signaling pathway 3 0 3 Ccl3, Lyn, Gm11787
T cell receptor signaling pathway 2 0 2 Syk, Lyn
Inflammatory response pathway 2 0 2 Il2, Cd86
IL-6 signaling pathway 2 0 2 Socs3, Lyn
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T cells skewing pathways genes for the Th17 lineage induction 
was than performed. The genes for IL-17f, IL-22, and Rorc were 
upregulated in F1 (SJL × B6Tlr2−) mice, although with a p-value 
higher than 0.05 (Figure S1B in Supplementary Material). The 
T cells transcriptomics data from the F1 (SJL ×  B6Tlr2−) mice 
suggested that these mice may be prone to develop a proinflam-
matory phenotype already at day 4 after CFA administration. 
Therefore, based on these findings, we decided to study the Th 
cell differentiation program in our mouse model to understand 
the impact of the Tlr2 polymorphism on T cells polarization 
during CFA immunization and EAE induction.
Tlr282ile Promotes the Bias toward Type 
1/17 of p139-specific response in lymph 
node cells
To confirm the observations obtained from microarray analysis 
suggesting that the Tlr2 polymorphism is able to modulate 
the balance of Th polarization and to examine its influence in 
an antigen-specific response, we next quantified the amount 
of mRNAs specific for cytokines produced by T cells and by 
antigen-presenting cells (APCs), and for lineage-specific nuclear 
transcription factors in unstimulated or p139-stimulated LNC 
(Figure  2A). We observed that the presence of Tlr282ile alone 
in F1 (SJL ×  B6Tlr2−) mice (full bars) resulted in a significantly 
higher basal level (p < 0.05) of the mRNAs specific for IL-6, IL-23, 
and IFN-γ, whereas it decreased significantly the basal levels of 
mRNAs for IL-10 and RORγ-T compared to the levels observed 
in LNC from F1 (SJL × B6wt) mice (open bars). Although the level 
of mRNA specific for IL-17A also appeared increased in mice 
having only Tlr282ile, in this latter case, the difference fell short of 
statistical significance (p = 0.17).
Following antigen stimulation, LNC from F1 (SJL × B6Tlr2−) 
mice showed a further increase of the levels of mRNAs specific 
for IL-6, IL-23, and IFN-γ. In addition, also the level of mRNA 
specific for IL-17A was significantly higher in the presence of 
Tlr282ile alone after antigen challenge.
The presence of Tlr282ile alone increased the expression of T-bet 
after p139 stimulation, which was consistent with the higher 
levels of IFN-γ specific mRNA, despite the fact that we observed 
only mild differences in levels of mRNA specific for IL-12b in 
either experimental condition. There were no significant differ-
ences in the levels of mRNA specific for RORγ-T  (despite the 
presence of higher values of mRNAs for IL-6, IL-23, and IL-17A) 
and GATA-3 under basal conditions or following stimulation 
with p139.
In apparent contrast with the observation of the proinflam-
matory attitude of immune LNC in mice carrying only Tlr282ile, 
we found that LNC from F1 (SJL × B6Tlr2−) mice also upregulated 
FoxP3 to a significant higher level than LNC from F1 (SJL × B6wt) 
mice, after antigen stimulation.
We next examined the levels of cytokines secreted by LNC. 
Cells obtained from F1 (SJL ×  B6Tlr2−) mice produced higher 
levels of IL-17A and antigen-driven secretion of IFN-γ (expressed 
as the ratio between values obtained after stimulation with the ag/
values in unstimulated cells) was also higher in F1 (SJL × B6Tlr2−) 
mice (Figure 2B). In addition, the amount of type 2 cytokines 
was similar in both groups with no antigen-dependent secretion 
of IL-4, IL-5, and IL-10 (Figure S2 in Supplementary Material). 
Thus, Tlr282ile promoted the polarization of T cell-dependent 
response toward type 1/17, whereas this effect was dampened by 
the presence of the allele 82met. The levels of IL-12 and IL-23 
were below the detection limit, and we could not determine if the 
difference in the secretion of cytokines by T cells was associated 
also with similar alterations of the secretion of directive cytokines 
by APCs, as suggested by Q-PCR data.
Tlr282ile Promotes the expansion of 
antigen-specific cD4+cD25+FoxP3+ cells
The results described above suggest that Tlr282ile promotes the 
expression of the mRNA specific for FoxP3 upon antigen stimula-
tion, despite inducing at the same time an increase of IFN-γ and 
IL-17A. Thus, our next aim was to establish if polymorphism at 
FigUre 2 | Tlr2 genotype regulates cytokines and T cell nuclear factors. (a) Groups of six F1 (SJL × B6wt) (open bars) and six F1 (SJL × B6Tlr2−) (closed bars) 
mice were immunized s.c. with p139 in enriched CFA. Each group of F1 mice was composed of three mice of two distinct litters. Lymph node cells were cultured for 
3 h with or without p139 as described in Section “Materials and Methods.” Effect of antigen stimulation on the levels of the mRNAs from cells obtained from LN 
draining the site of immunization in F1 (SJL × B6wt) (open symbols) and F1 (SJL × B6Tlr2−) (closed symbols) specific for the cytokines: IFN-γ, IL-17A, IL-10, IL-13, 
IL-5, IL-6, TGF-β, IL-12b, and IL-23, and for nuclear transcription factors: FoxP3, T-bet, RORγ-T, and GATA-3. Levels of mRNA specific for the cytokines and for the 
transcription factors mentioned above were analyzed by qRT-PCR as described in Section “Materials and Methods” and reported as fold increase (boxplot) after 
normalization of the amount of each specific mRNA vs. the average value obtained from the unstimulated LNC of F1 (SJL × B6wt) mice (two-tailed Mann–Whitney 
test, *p < 0.05, **p < 0.01). qRT-PCR reactions were performed in triplicate for each sample from mice of both groups. (B) Groups of six F1 (SJL × B6wt) (open bars) 
and six F1 (SJL × B6Tlr2−) (closed bars) mice from two distinct experiments were immunized s.c. with p139 in enriched CFA. Lymph node cells were cultured for 18 h 
with or without p139 as described at Section “Materials and Methods.” The graphics reports the effect of antigen stimulation on the production of IL-17A and IFN-γ 
as ratio between p139 and Ag- (two-tailed Mann–Whitney test, *p < 0.05). The cytokines quantification was performed by Macsplex® as described in Section 
“Materials and Methods.”
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position 82 of Tlr2 has an effect on the number of antigen-specific 
CD4+CD25+FoxP3+ population.
To this end, we immunized F1 mice with p139 and established 
the frequency of CD4+CD25+FoxP3+ cells among total CD4+ 
LN-derived cells by flow cytometry. The results showed that the 
stimulation with p139 significantly increased the frequency of 
CD4+CD25+FoxP3+ cells in F1 (SJL × B6Tlr2−) mice, but not in F1 
(SJL × B6wt) mice (Figure 3). No effect of the polymorphism could 
be observed when we examined the levels of CD4+CD25−FoxP3+ 
or CD4+CD25+FoxP3− cells. Thus, the allele Tlr282ile promoted, 
whereas the allele Tlr282met dominantly dampened the expansion 
of FoxP3+CD4+ cells in response to antigen.
FigUre 3 | Tlr2 genotype regulates Treg levels. Ten F1 (SJL × B6wt) (open bars and symbols) and nine F1 (SJL × B6Tlr2−) (closed bars and symbols) mice from 
three distinct experiments were immunized s.c. with p139 in enriched CFA. The mice were sacrificed at day 12 after immunization. Lymph node cells were cultured 
for 18 h with or without p139 as described in Section “Materials and Methods.” Cells were stained for CD4, CD25, and FoxP3, and analyzed by flow cytometry.  
(a) Gating of CD4+CD25+FoxP3+ cells; (B) percentage (boxplot) of CD4+CD25+FoxP3+ cells upon total CD4+ cells and as (c) ratio (boxplot) between percentages of 
CD4+CD25+FoxP3+ cells upon total CD4+ in stimulated and unstimulated cells per group (two-tailed Wilcoxon matched-pairs signed rank test *p < 0.05).
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Together, these data suggest that allele Tlr282ile promotes pro- 
and anti-inflammatory immune responses, whereas Tlr282met 
dominantly downmodulates polarization to Type1/17 and Treg 
cells.
activation of Tlr2 by Pam2csK4 or 
Pam3csK4 on cD62high or cD62low T cells 
Does not Modify the number of 
cD4+cD25+FoxP3+ cells
We have previously demonstrated that the effect of polymorphism 
Ile82Met on T cell exit from LNs is due to Tlr2 expressed on T 
cells. It had been previously reported that Tlr2 is expressed 
mainly on CD4+CD25+ T cells; its ligation by HSP60 on purified 
Tregs leads to an increase in the regulatory ability of Treg cells 
(26), while others showed conflicting evidences about effects 
of ligation of Tlr2 by Pam3CSK4 in purified Tregs (27, 28). To 
address the role of Tlr2 expressed on T cells in Treg polarization, 
we isolated CD62high and CD62low T cells from naive SJL mice, 
stimulated them with Pam2CSK4 or Pam3CSK4, in the absence 
or presence of αCD3ϵ + αCD28. The results (Figure 4A) showed 
that treatment with αCD3ϵ + αCD28 expanded the number of 
CD4+CD25+FoxP3+ cells, mainly in the CD62low T cells, thus 
confirming in the parental strain SJL (Tlr282Ile) the observations 
reported in Figures 2 and 3 for the ag-driven response in LNC 
of F1 mice (SJL × B6Tlr2−). Ligation of Tlr2 did not modify such 
an expansion. It was previously shown that CD44/alpha-galectin 
9 is involved in the regulation of Treg polarization. However, we 
found no effect on Treg expansion of the presence of anti-galectin 
9 antibodies (data not shown). Taken together, these data contrast 
with the hypothesis that the modulation of Th polarization by Tlr2 
haplotype observed is due to the effect of ligation of Tlr2/Tlr1 or 
Tlr2/Tlr6 expressed by T cells, following or during T cell priming.
Pam2csK4 or Pam3csK4 as adjuvants 
Does not reproduce the effect of Tlr2 
Polymorphism at Position 82
Tlr2 can form dimers with several distinct co-ligands such as 
Tlr1 and Tlr6, the main co-receptors, Tlr10 and, possibly, Tlr2 
itself, leading to differences in the pattern of molecules that 
each dimer can bind. A potential difference in the ability of Tlr2 
isoforms to favor the dimerization with Tlr1 or Tlr6 may justify 
FigUre 4 | (a) FoxP3 levels are not regulated by Tlr2 expressed on T cells. CD4+CD62Llow and CD4+CD62Lhigh T cells were enriched from spleen cells of five naive 
SJL mice as described in Section “Materials and Methods.” CD4+CD62Lhigh cells were pooled together. The cells were cultured for 18 h with or without Pam2CSK4 
or Pam3CSK4 and with or without αCD3ϵ + αCD28. Cells were stained for CD4, CD25, and FoxP3, and analyzed by flow cytometry. Results are showed as 
percentage + SD of CD4+CD25+FoxP3+ cells on total CD4+ cells (one-way ANOVA, Bonferroni’s multiple comparison test **p < 0.01; ***p < 0.001). (B) Pam2CSK4 
or Pam3CSK4 as adjuvants do not modulate cytokines and T cell nuclear factor FoxP3. Eight female SJL mice were immunized s.c. with p139 in IFA mixed with 
Pam2CSK4 (four mice, open bars) or Pam3CSK4 (four mice, closed bars). Draining lymph node cells were cultured for 6 h with or without p139 as described in 
Section “Materials and Methods.” The graphics report the effect of antigen stimulation on the production of cytokines (boxplot). Cytokines quantification was 
performed by SybrGreen qPCR.
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the differences between Tlr282ile and Tlr282met in their ability to 
regulate polarization of T cells. To address this point, we immu-
nized SJL mice using as adjuvant IFA with Pam2CSK4, a selective 
ligand for Tlr2/Tlr6 dimers, or Pam3CSK4, a selective ligand for 
Tlr2/Tlr1 dimers, and studied the levels of mRNA specific for 
IL-17A, IL-13, IFN-γ, and FoxP3. Although LNC derived from 
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mice  challenged in the presence of Pam2CSK4 displayed a slightly 
higher  production of IL-17A, the results showed no statistically 
significant difference between mice immunized using the two 
selective ligands (Figure  4B), thus suggesting that effects of 
polymorphism Ile82Met could hardly be explained by preferen-
tial dimerization of Tlr2 with either Tlr1 or Tlr6.
Notably, both Pam2CSK4 and Pam3CSK4 induced an antigen-
driven-like upregulation of pro-inflammatory cytokines, but 
neither was able to induce antigen-driven upregulation of FoxP3 
in LNC (Figure  4B). This observation indicates that Tlr282ile 
regulates the differentiation of Th cells toward antigen-dependent 
Treg phenotype after dimerization with co-receptor(s) other than 
Tlr1 or Tlr6, and excludes the possibility that Tlr282ile fails to block 
a default expansion of Treg cells.
The Polymorphism ile82Met Modifies the 
Binding Pockets of Tlr2
To have further indications about the mechanisms that sustain 
the ability of Met/Ile substitution at position 82 to modulate sig-
nificantly the immune response, we examined in silico the effect 
of this polymorphism on the three-dimensional structure of Tlr2.
The analysis of putative binding to variant Tlr282ile revealed that 
the Ile itself is a binding residue to several sugars, as determined 
by COFACTOR server, predicting ligand-binding sites using Tlr2 
tertiary structure (Figure 5A). Cadherin preproprotein domain 
(aa 156–254), specifically cadherin 1/E-cadherin (Homo sapiens) 
and cadherin 11 (Mus musculus), was both found to bind to 
multiple residues. These included residue 79 and the mutated 
Met to Ile 82 (enumerated as residues 55 and 57 of the molecular 
model shown in Figure 5, due to the absence of the leader peptide 
in the crystallography model) (Figure 5A). Interestingly, the same 
amino acid sequence of E-cadherin predicted to bind to Tlr2 was 
found to bind also to Listeria invasion protein internalin, as found 
by blastp in pdb harbored sequences (not shown).
We modeled an 82Ile mutant Tlr2 version, using the crystal-
lography model of Tlr282met and two different modeling approaches. 
First, one was using a template-based structure prediction mod-
eling by I-Tasser web server. The second one was using the same 
Tlr282met model and rotamer substitution, followed by molecular 
dynamics (MD)-based molecular refinement. This MD refinement 
was achieved using energy minimization, salvation, and molecular 
equilibration (AMBER-based protocol, MDWeb server). MD 
simulation allowed for studying the atomic and molecular move-
ment and interaction trajectories for a short fixed period of time, 
giving a view of the dynamical evolution of the system. We found 
that 82Ile inflicts lesser fluctuation of the energy minimized and 
solvated Tlr2 molecule in general, as shown by differing RMSd tra-
jectory (RMSd vs. frames function, showing changes in molecular 
3D structure in space) having less peaks in Tlr282ile vs. Tlr282met 
(Figure 5B). There was significant difference in their fluctuations 
and spatial shift in Ile holding β-sheet (visualized by Chimera 
trajectory analysis tool, after fixing the C-amino terminus of the 
Tlr2 chains and superimposing Tlr282met with Tlr282ile models).
Following RMSd fluctuations (global and Cα backbone, 
VMD Timeline tool) along the energy minimization trajectory, 
we found that maximal fluctuations differ within the range of a 
hydrogen bond, ~2 Å (from 5.669 to 7.257 Å) (Figure 5C). Even 
though residue 82Met–Ile was not the major residue displace-
ment contributor within the whole molecule, it still demonstrated 
a center of fluctuation of more than ~1 Å (which is in the range of 
C–H or C–C chemical bond) (Figure 5D).
Following the total number of H-bonds formation dynamics 
in time, the dynamics in H-bonds number in a 10  Å vicinity 
of the 82Ile residue, and the distance between superimposed 
Tlr282met and Tlr282ile terminal C-atoms, we found that at specific 
time points the mutant Tlr2 had highest RMSd and residue dis-
placement peaks, compared to wild-type (82Met) (as estimated 
by VMD Timeline tool: frames 4–5, 10–12, 14–15, and 19–20) 
(Figure 5E). This phenomenon corresponded to highest number 
of H-bonds in mutated Tlr2, suggesting that the moments when 
MD of Tlr2 caused its major deviations from wild-type structure, 
these very moments were strengthen with higher number of 
instant H-bonds. These fluctuation and displacement alterations 
were accompanied with changes in secondary structure of the 
Tlr282ile minimized energy form resulting in several α-helixes 
loss across the β-sheets at the side of 82Ile containing mutation 
(Figure 6A). Importantly, at same MD trajectory time points, the 
Tlr282ile model have also demonstrated decreased volume of its 
ligand–receptor interface cavity (Figure 6B). Further, the changes 
in the specific ligand-binding pocket itself were measured. It is 
usually smaller than the whole interaction interface. Pam2CSK4 
pocket was estimated in non-minimized and energy-minimized 
conditions accordingly: 1440 and 981.5 Å3 (wild-type Tlr282met); 
1067 and 805.1 Å3 (mutated Tlr282ile). Thus, in steady-state condi-
tions, the ligand-binding pocket of the wild-type molecule was 
reduced by 458.5 Å3, while mutated molecule pocket was reduced 
by only 261.9 Å3. Overall, the mutation incurred 176 Å3 reduc-
tion in pocket volume. The data suggesting that the rigidity, and 
increased H-bonding ultimately resulted in decreased binding 
cavity and decreased likelihood of binding of cognate ligands to 
Tlr2 (Figure 6B). This reduced likelihood was validated by assess-
ing the binding energy that was significantly increased, reflecting 
the observed molecular rigidity [ABPS-binding E of −21.6  kJ/
mol (82Met) vs. 26.5 (82Ile) kJ/mol] (Figure 6C).
Overall, binding prediction and MD data suggested the 
mutant causes an increased molecular rigidity manifested by 
decreased number of higher amplitude molecular fluctuations, 
corresponding to an increased H-bonds formation. This was 
further supported by extension of three of the β-sheets, reduction 
of volume of ligand-binding cavity at the same time points as the 
ones with increased molecular rigidity, and an increased energy 
of ligand binding, resulting ultimately in lesser ligand-Tlr282ile 
receptor interactions.
The Polymorphism on Position 82 of 
Tlr2 Modulates severity of eae
We have previously shown that the polymorphism of Tlr2 modu-
lates T cell trafficking (30). Here, we have shown that each isoform 
of Tlr2 displayed a set of distinct pro- and anti-inflammatory 
properties with Tlr282ile promoting type 1/17 polarization and 
the expansion of antigen-specific FoxP3+ Tregs, and Tlr282met 
blocking the expansion of Tregs and that of production of 
FigUre 5 | continued
12
Piermattei et al. TLR2 Janus Role in Immune Response
Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 191
IFN-γ and IL-17A. We therefore asked if the distinct pro- and 
anti-inflammatory effects of the two isoforms balanced each 
other, or if they impacted differently course and histopathology 
of an autoimmune disease model such as EAE.
To this aim, F1 mice were immunized s.c. with p139, and 
EAE development was monitored for the following 60  days 
(Figure 7). Overall, disease severity was milder than that previ-
ously reported for SJL mice; this effect may be due to the fact 
that F1 mice display a lower level of expression of the appropri-
ate MHC restricting elements with respect to the parental strain. 
When we compared the two types of F1 mice, we found that F1 
(SJL × B6Tlr2−) mice developed a slightly earlier and more severe 
disease than F1 (SJL × B6wt) mice (Figure 7A), indicating that 
the presence of Tlr282met attenuated EAE. PTx administration 
accelerates EAE in both F1 mice (Figure 7B), and the average 
total disease scores were increased in both types of F1 mice, 
more significantly in F1 (SJL × B6wt) mice (p = 0.0002 for F1 
(SJL × B6wt) mice, p = 0.01 for F1 (SJL × B6Tlr2−) mice). However, 
after PTx administration, there was no statistical difference in 
the average total score of disease between the two groups, sug-
gesting that PTx can overcome the difference in global severity 
due to Tlr2 (Figure 7C). Nevertheless, an interesting observation 
was that the clinical course of disease after treatment with PTx 
was not similar in F1 (SJL × B6Tlr2−) and F1 (SJL × B6wt) mice. In 
fact, a peak of disease severity was observed around day 20 after 
immunization in F1 (SJL × B6Tlr2−) mice, then a decrease of the 
average disease score between day 20 and day 30 followed by a 
new increase of the disease severity. The course of disease in F1 
(SJL × B6wt) mice showed no signs of remission. The quantifica-
tion of this difference following PTx administration is presented 
in Figure 7D showing the maximum of score decrease before 
day 30 after immunization, with F1 (SJL × B6Tlr2−) mice show-
ing a significantly more considerable reduction of disease score 
compared to F1 (SJL × B6wt) mice (p = 0.02).
F1 (SJL × B6Tlr2−) mice have a reduced Tlr2 gene dosage, and 
we have previously demonstrated that the lower gene dosage of 
these mice did not lead to a difference of TLR2 expression (30). 
To assess if the reduction of the EAE severity was a function 
of the higher gene dosage in F1 (SJL × B6wt) with respect to F1 
(SJL × B6Tlr2−) mice, we induced EAE in littermates that were either 
F1 (SJL × B6Tlr2−) mice, having one copy of functional Tlr2 of SJL 
origin, or F1 (SJL × B6ts), having two copies of functional Tlr2 
of SJL origin. As described in Section “Materials and Methods,” 
B6ts mice are mice of the B6 background carrying Tlr2 of SJL, 
FigUre 5 | ligand-binding site prediction and molecular dynamics demonstrate 82ile replacement of 82Met in Tlr2 to produce new sugar-binding 
sites and more rigid molecule. (a) 82Ile SNP mutation increases likelihood of binding sugars such as NAG. Ligand-binding site prediction based on COFACTOR 
server reveal that multiple sugars such as NAG, BMA, MAN (left), and protein domains of cadherin family such as 1/11-cadherin (right). The binding interface 
residues are depicted in green and orange. The SNP mutation replacing 82Met with 82Ile in original Tlr2 sequence is direct binding site for NAG as shown in the 
table (below). The SNP is represented as Ile57 in the Tlr2 crystallography model (signal peptide is missing). (B–e) Molecular dynamics reveals 83Ile mutation causes 
less molecular fluctuations with greater amplitude and total and local intramolecular H-bonds inferring an increased molecular rigidity. (B) Tlr2 (82Met) and Tlr2 (82Ile) 
models were subject to energy minimization and solvation using AMBER MD suite (MDWeb server) and followed by normal mode analysis (anisotropic network 
model) (Protein Energy Landscape Exploration server). Trajectory analysis (RMSd vs. frames) revealed reduced number of peak fluctuations (left). Molecular 
displacement of the final energy minimization frame(s) of Tlr2 (Met) vs. Tlr2 (Ile), after C-terminus was held steady (right). (c) Zoom on time-dependent per-residue 
root mean square deviation plot of Tlr2 (Met) vs. Tlr2 (Ile) (left and right, respectively) with peak fluctuation maximum of 5.699 Å for Met82 vs. 7.275 Å for Ile82. In 
(D) only, Met vs. Ile RMSds by frame are shown. (e) Per-frame trajectory analysis of the number of established H-bonds in each of the Tlr2 variants (left). Number of 
H-bonds in 10 Å vicinity of the Met/Ile residues (pos 57) (middle). Per-frame distance between 57Met (CE) and 57Ile (CD1) of respective Tlr2 wt and mutant molecule 
structures (right).
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and obtained by back-crossing of Tlr2 of SJL onto B6Tlr2− for nine 
generations. No difference in the disease course and average 
total score was observed between these two groups (Figure S3 in 
Supplementary Material), confirming that it was the presence of 
the allele Tlr282met rather than gene dosage of Tlr2 that reduced 
the severity of EAE.
In conclusion, our data suggest that allele Tlr282met behaves as 
a dominant modulator of EAE in F1 (SJL × B6wt) mice, where 
it reduces the severity of EAE following challenge with p139 in 
adjuvant, in the absence of PTx administration. The presence 
of allele Tlr282ile alone, however, resulted in a higher degree of 
symptoms remission after PTx administration.
FigUre 6 | Molecular dynamics and ligand–receptor energy assessment studies reveal 82ile replacement of 82Met in Tlr2 to change molecules 
tertiary structure, ligand pocket volume, and binding energy, inferring lesser probability of ligand binding.  
(Continued)
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(a) Secondary structure differences revealed by molecular dynamics trajectory – structural models (top) and MUSCLE sequence alignment (bottom). Highlighted in 
yellow – α-helixes; in green – β-sheets. (B) Comparison of volume of ligand–receptor interface cavity measured using Intersurf in TLR2 wt (Met) vs. mutated (Ile) and 
the ligand PAM2CSK. The analysis is done on molecular dynamics trajectory. (c) Structural models of Tlr2 (Met)/(Ile) showing binding interface with PAM2CSK. 
APBS binding energies (BE) are shown below.
FigUre 6 | continued
FigUre 7 | Polymorphism at position 82 of Tlr2 modulates severity and course of eae. EAE score was evaluated as described in Section “Materials and 
Methods.” In all panels, data report the cumulated results of two independent experiments each comprising comparable numbers of mice from the genetic 
backgrounds examined in each panel; mice were evaluated daily for 60 days in a blind fashion with respect to genotype. Closed symbols and bars report data from 
F1 (SJL × B6Tlr2−) mice; the open symbols and bars report data from F1 (SJL × B6wt) mice. (a) The average disease score in 12 F1 (SJL × B6Tlr2−) and 17 F1 
(SJL × B6wt) mice immunized with p139 without treatment with PTx. (B) The average disease score in 10 F1 (SJL × B6Tlr2−) and 18 F1 (SJL × B6wt) mice immunized 
with p139 and treated with PTx at day 0 and day 3 after immunization. (c) Total score of the diseases described in (a,B) are reported as boxplot. (D) Maximal 
decrease of disease score between day 20 and day 30 after immunization are reported as boxplot (two-tailed Mann–Whitney test, **p < 0.01).
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Tlr282met reduces lesion load in the 
Frontal lobes
CNS lesions in EAE are largely limited to the spinal cord, a major 
difference with MS, in which lesions are largely present in the 
forebrain. Since we had previously observed that polymorphism 
Ile82Met of Tlr2 affects the trafficking properties of T cells, we 
next examined if it also influences the distribution of lesions in 
the CNS (Table 2; Figures 8A–C).
We observed no qualitative differences in the neuropatho-
logical changes in the spinal cord, brain stem/cerebellum, and 
hippocampus/thalamus associated with Tlr2 polymorphism 
(Figure 8C). Notably, 73% of F1 (SJL × B6Tlr2−) mice showed the 
presence of lesions in the frontal lobes, whereas only 33% of F1 
(SJL × B6wt) mice exhibited lesions in these areas. We observed 
a statistically significant lower lesion load between the frontal 
lobes and spinal cord only in the F1 (SJL × B6wt) mice (p = 0.049), 
TaBle 2 | Presence and grade of infiltration in cns of F1 (sJl × B6wt) and F1 (sJl × B6Tlr2−) during eae.
F1 (sJl × c57wt) F1 (sJl × c57Tlr2−)
a B c D e F g h J N = 9 K l M n O P Q r s T U N = 11
Score of disease 2.75 2.5 2 1.25 1.5 1.5 1.5 3 1.75 1.25 1.75 2.25 2.25 2 2 3 1.75 3 1.25 3
Day of sacrifice 16 17 16 37 22 21 22 15 18 22 22 21 18 21 16 21 16 16 37 17
+(%)b +(%)b
Frontal polesa 1 0 0 0 0 2 0 2 0 3 (33%) 1 1 0 1 1 1 0 1 1 0 1 8 (73%)
Hippocampus/
thalamusa
1 0 2 0 1 1 1 1 1 7 (78%) 1 0 1 1 1 2 0 1 NA 0 2 7 (70%)
Cerebellum/
brainstema
2 0 3 0 1 1 1 1 1 7 (78%) 1 1 1 1 1 3 0 2 1 1 1 10 (91%)
Spinal corda 2 3 1 2 1 0 1 2 1 8 (88%) 1 1 2 2 2 0 2 1 1 0 1 9 (82%)
aFor each CNS area, five regularly spaced serial sections were examined. Scores were attributed to each area according to the scale reported in Figure 7A. 0 = no infiltration found 
in any of the sections. Data report the highest score obtained.
b% of mice scoring ≥1 in at least one section from the indicated area/mice examine.
FigUre 8 | continued
16
Piermattei et al. TLR2 Janus Role in Immune Response
Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 191
suggesting that Tlr282ile promotes and Tlr282met prevents the infil-
tration of the frontal lobes.
cytokine and FoxP3 Profile in the cns
As shown in Figures  8A,B, the neuropathology features of the 
lesions in both F1 mice appear similar, including the presence of 
CD3+ cells and activated microglia (Figure 8B). When we assessed 
the profile of mRNAs specific for cytokine in cells infiltrating the 
CNS at the peak of disease, we found a statistically significant 
difference for TGF-β production, which was significantly higher 
in the CNS of F1 (SJL × B6Tlr2−) mice (Figure 8D). No difference 
was observed in the amount of IL-12, IFN-γ, IL-17A, and IL-23 
FigUre 8 | Tlr2 genotype decreases the frequency of infiltrates in the frontal poles of the cns and the cytokine and FoxP3 levels in cns-infiltrating 
cells. (a–c) 10 F1 (SJL × B6wt) (open bars) and 12 F1 (SJL × B6Tlr2−) (closed bars) mice were immunized s.c. with p139 in enriched CFA and treated with PTx. Data 
report the results of two independent experiments, each comprising mice of either genetic background. Mice were sacrificed at the disease peak and CNS histology 
was performed with H&E staining, as described in Section “Materials and Methods.” Part of these mice undergone IHC staining for CD3 and IB4. One section every 
100 μm was examined, blind with respect to genotype and score of disease. (a) Representative images from H&E staining of mice brains coronal sections. Grade 1: 
presence of infiltrates limited to vessels and meninges (medulla oblongata); Grade 2: considerable presence of infiltrates in the parenchyma (hippocampus); and 
Grade 3: severe presence of infiltrates in the parenchyma (cerebellum), scale bar 100 μm. (B) Representative images from IHC staining for CD3 (scale bar 200 nm) 
and IB4 (scale bar 100 nm). (c) Frequencies of mice that present lesion distributions in different areas of the CNS in F1 (SJL × B6wt) (open bars) and F1 
(SJL × B6Tlr2−) (closed bars) in at least one section per each of the area indicated (χ2 test, *p < 0.05). (D,e) Six F1 (SJL × B6wt) (open bars) and five F1 (SJL × B6Tlr2−) 
(closed bars) mice were immunized s.c. with p139 in enriched CFA. F1 (SJL × B6Tlr2−) mice were sacrificed when the score of disease had reached a value at least 
above 1. Each group of F1 mice was composed of three mice of two distinct litters. CNS-infiltrating cells were isolated by Percoll gradient and the levels of mRNA 
specific for (D) IFN-γ, IL-17, IL-10, IL-13, IL-12b, IL-23, TGF-β, and IL-6, and (e) FoxP3 were evaluated by qRT-PCR as described in Section “Materials and 
Methods.” The levels of mRNAs expression are expressed after normalization vs. the average value obtained from CNS-infiltrating cells of F1 (SJL × B6wt) mice. 
qRT-PCR reactions were performed in triplicate. Results are reported as boxplot (two-tailed Mann–Whitney test, *p < 0.05, **p < 0.01).
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mRNAs. Consistent with the data obtained in the LNC (Figure 2), 
the cells infiltrating the CNS of F1 (SJL × B6Tlr2−) mice displayed also 
significantly higher levels of FoxP3-specific mRNA (Figure 8E).
DiscUssiOn
In the present work, we exploited the polymorphism Ile82Met 
to investigate the role of Tlr2 in the proinflammatory and anti-
inflammatory effects of adjuvant containing Mtb, in  vivo. We 
found that each isoform of Tlr2 displayed a set of distinct pro- and 
anti-inflammatory properties. Upon usage of the same adjuvant, 
Tlr282ile promotes polarization of T cell mediated responses toward 
a type 1/17 phenotype and the expansion of antigen-specific 
FoxP3+ Tregs, whereas Tlr282met blocks the expansion of Tregs 
and reduces the production of IFN-γ and IL-17A. Both pro- and 
anti-inflammatory effects of the polymorphisms appear associ-
ated with modification of the secretion of the directive cytokines 
produced by the APC, and we found no evidence of a role for 
Tlr2/Tlr1 or Tlr2/Tlr6 dimers in the regulation of expression of 
FoxP3 by CD4+CD25+ T cells, in  vitro directly on T cells, and 
in  vivo. When we studied in  silico the effect of polymorphism 
at position 82 on Tlr2, we observed that this residue influences 
at a distance the primary binding pocket of Tlr2, and also is 
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directly involved in a candidate secondary pocket that may bind 
sugars and cadherins. We also found significant differences in 
the EAE course and neuropathology in F1 (SJL ×  B6wt) vs. F1 
(SJL × B6Tlr2−) mice, indicating that effects of Tlr2 polymorphism 
on the immune response are translated into immunopathology.
Thus, Tlr2 mediates in vivo pro- and anti-inflammatory effects 
of Mtb, and can modify the clinical course and neuropathology 
during EAE.
Thus, the presence of functional differences between the poly-
morphic forms of Tlr2 provided a unique opportunity to dissect 
its role in vivo, bypassing the limitation of KO models in which 
knocking-out Tlr2 abolishes all of the distinct effects of its various 
dimers. Although, according to the limited genetic differences 
that exist between the two types of F1 mice, the absolute values 
of differences are small, for several of them statistic significance 
is achieved. Thus, our observations define Tlr2 as a molecular 
link between infectious history and modulation of the course of 
autoimmunity, in which, however, it plays a janus role.
Tlr2 promotes the secretion of directive cytokines, such as 
IL-12 and IL-23 by DCs (53, 54) and acts directly on T cells, in 
particular regulating in the periphery the balance between Th17 
and Tregs (24, 25). It has been reported that T cells migrated at the 
sites of autoimmune inflammation have a Th1/Th17 cell-like phe-
notype, producing high levels of IL-17 and IFN-γ (55, 56). Even 
if the mechanisms that govern plasticity of Th17 cells are unclear, 
the transcription factor RORγ-T does not appear to be involved in 
the development of T cells expressing this hybrid Th1/Th17 profile 
(57). TLR2 has been shown to convert FoxP3+ Treg to Th17 (25), 
and to suppress polarization of Th cells to a Treg phenotype. In 
turn, Th17 cells can transdifferentiate to Treg during the resolu-
tion of inflammation driven by anti-CD3 administration (58).
Our finding that Tlr282met determines a decrease in the amount 
of IFN-γ, IL-17A, and of the mRNA specific for T-bet, following 
in vivo challenge and after p139 stimulation in vitro, but not for 
RORγ-T is consistent with the hypothesis that Tlr282ile promotes 
the acquisition of a Th1/Th17 cell-like phenotype whose develop-
ment is linked to the expression of T-bet, but does not require 
expression of RORγ-T.
In tandem, Tlr282ile promoted the acquisition of an antigen-
dependent Treg phenotype, detected in vitro (Figures 2 and 3), 
and suggested in vivo in the CNS by mRNA evaluation (Figure 8).
It has been reported that Treg development is regulated by 
IL-1R through MyD88 (59). It has also been reported that IL-1b 
promotes Th17 polarization of naive T cells by favoring the 
alternative splicing of FoxP3-specific mRNA thus generating 
an isoform of FoxP3 lacking exon 7 that promotes the secretion 
of IL-17 (60). The findings reported here point to Tlr2 as a new 
player in the MyD88-dependent modulation of Treg phenotype.
It will be important to establish if the T cells able to transdif-
ferentiate between Th1/17 and Treg represent a defined popula-
tion regulated by Tlr2, or rather if Tlr2 regulates independently 
the acquisition of a type 1/17 and of a Treg phenotype. In our 
previous work, we showed that, in addition to the expected robust 
CD4-mediated IFN-γ response (61), challenge of SJL mice with 
p139 in CFA elicits also a smaller, but measurable, p139-specific 
CD8-mediated response (4). It has been reported that induction 
of Tc17 phenotype by CD8+ cells following fungal infections is 
dependent on Tlr2 and MyD88, while induction of Tc1 pheno-
type is not (62). Thus, we cannot formally exclude that a part of 
the effect of the Tlr2 haplotype on the polarization of the response 
to type1/17 can also involve p139-specific CD8 T cells. However, 
in our model, both IFN-γ and IL-17A are regulated in parallel 
by Tlr2 haplotype, thereby hinting that we may rather be dealing 
with a CD4-related effect.
Tlr2 has the widest repertoire of ligands among pathogens’ 
receptors, co-acting with a variety of other molecules. Its main 
site binding for peptidoglycan lies distant from the polymorphic 
residue 82 (11, 63). We showed that the functional differences 
between Tlr282ile and Tlr282met could not be explained by the 
preferential dimerization with Tlr1 or Tlr6 (Figure  4), hinting 
that other co-receptors and ligand(s) are most likely responsible 
for the induction of antigen-specific FoxP3+ T cells. To gain 
some hints about how a substitution at this position can affect 
the functions of TLR2, we examined in  silico the structural 
consequences of this polymorphism. The binding prediction, but 
especially MD modeling and ligand-binding energy assessment 
revealed that 82Ile replacement of 82Met created changes favor-
ing new small molecules (sugars and E-cadherin) binding and 
perturbation in normal molecular fluctuations. The latter is based 
on tertiary structure modification due to loss of α-helical and 
increase of β-sheet structural properties of Tlr2. These changes 
ultimately result in more rigid molecular fluctuations, decreased 
ligand–receptor pocket volume, and non-favorable energy of 
binding, stabilized by an increased number of H-bonds. Overall, 
MD methodology is superior to mere ligand–receptor docking 
studies, providing an insight on molecular specificities causing 
structural–functional relationships. In this study, dynamics and 
energy changes incurred by 82Met mutation ultimately resulted 
in unfavorable binding energy and lesser probability of further 
signal transduction.
The results indicate two possible mechanisms, which are 
not mutually exclusive. The first suggests that the position 82 
influences the flexibility and size of the main binding grove, 
with 82Met resulting in a larger and more flexible pocket; as a 
consequence, the binding pocket of Tlr282met may accommodate 
a wider repertoire of ligands, thus explaining its dominance in 
heterozygous F1. In addition, we identified a surface around resi-
due 82, potentially able to bind sugars or (self)-proteins, whose 
binding properties were modified by the substitution. This latter 
observation raises the issue of the possibility that large repetitive 
molecules may bind to Tlr2 along a model of interaction similar 
to that of the other Tlrs, i.e., involving its horseshoe domain.
To the best of our knowledge, there are no common polymor-
phisms of Tlr2 in any of the first three LRR regions of the mol-
ecule in humans (64). We have recently shown that PE-PGRS33 
of Mtb enhances the entry of Mtb into the macrophages through 
Tlr2 (65), and preliminary data indicate that residue 82 may be 
directly involved in the interaction between PE-PGRS33 and 
Tlr2. An evolutionary pressure exerted by Mtb may be a reason 
for the lack of polymorphisms in this region, in humans.
Data on the role of Tlr2 in EAE and MS are conflicting. It was 
reported that Tlr2-KO mice develop EAE (66), but evidences also 
exist indicating that Tlr2 plays a role in sustaining EAE (67). Tlr2 
ligands were found in the CNS of MS patients (68), and Tlr2 is 
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expressed on several cell types involved in disease determination 
(25). The possibility that activation of Tlr2 influences the course 
of MS is still debated (69).
Treatment with isoniazid (INH) still represents the center-
piece for treatment of tuberculosis. INH is frequently associ-
ated with the development of drug-induced LES. Although 
it was originally supposed that INH acts by haptenization of 
self-proteins, more recent data suggest that it alters the control 
mechanisms of immune responses (70). The case of a 39-year-
old man that developed a primary progressive MS after therapy 
with INH to treat a latent Tbc (71) supports the hypothesis that 
latent Mtb infections can actually provide anti-inflammatory 
effects in some cases.
As mentioned above, both Tlr282met and Tlr282ile have anti-
inflammatory properties that, however, impact differently on 
the clinical course of EAE. Tlr282met leads to a relative reduction 
of the production of proinflammatory cytokines and a milder 
disease severity. In F1 mice expressing only Tlr282ile, we observed 
a relatively higher level of proinflammatory cytokines but also 
the significant presence of antigen-specific CD4+CD25+FoxP3+ 
T cells and found the presence of increased levels of FoxP3 mRNA 
in the CNS at the peak of disease, associated with a small but 
significant remission of symptoms. The depletion of Treg cells in 
SJL mice was shown to increase EAE severity and to reduce late 
remission (72). Our findings are consistent with the hypothesis 
that inducible Tregs may have a role in the induction of remission 
rather than in regulating the overall severity of the disease.
The distribution of inflammatory infiltrates in the CNS is one 
of the main differences between MS and most models of EAE 
(73), and the distribution of lesions in the brain of MS patients is 
extremely variable, contributing to the poor predictability of the 
clinical disease. Our data showed that also the presence of mild 
infiltrates in the frontal poles is dictated by the Tlr2 haplotype 
(Figure 8). Trafficking of T cells is correlated with Th polariza-
tion (74), which we show to be modulated by Tlr2 haplotype. In 
addition, we report that CCR2 mRNA is likely directly regulated 
by Tlr2 haplotype (Table 1). CCR2 has a central role in the trans-
migration of blood cells into the CNS (75). We have also found 
some mild differences of the expression of cell surface markers 
related to trafficking across endothelia (namely, CD49 and CD44) 
apparently linked to Tlr2 haplotype in antigen-activated T cells 
(manuscript in preparation). To our knowledge, there are no 
reports of trafficking pathways involved in the recruitment of self-
reactive T cells to specific areas of the CNS. Thus, the possibility of 
the involvement of these molecules in the selection of areas of the 
CNS as targets of inflammation needs to be assessed.
The finding that the odorant receptors (ORs) represent one of 
the pathway regulated by Tlr2 polymorphism in our microarray 
analysis was unexpected. OR genes comprise more than 1200 
genes in mouse. Two groups reported a functional relationship 
between ORs and leukocytes, showing that ORs are involved in 
the maintenance of blood leukocytes precursors in Drosophila 
(76) and that ORs and taste receptors distribute differentially 
among the subpopulation of leukocytes (77). A cluster of ORs is 
located near to the MHC locus, and it was suggested to link mat-
ing behavior to immune responses (78), although this hypothesis 
has not been confirmed (79). However, none of the ORs, which 
we found to be regulated by Tlr2, belong to this cluster, while 
they are spread among various chromosomes. Toll-6 and Toll-7 
in Drosophila have been shown to be involved in the regulation 
of the olfactory circuits by neurons (80). Whether the findings 
reported here indicate the preservation of an essential pathway, it 
requires further investigation.
Our study point to Tlr2 as a key molecule in the pathway 
mediating the janus effects of administration of mycobacterium-
derived products to self- and allo-reactive immune responses 
in vivo. Given the complex and in contradictory effects that PRRs 
and in particular Tlr2 engagement has on immune responses, a 
better definition of their role in human disease is needed, before 
interference with these molecules can be proposed as a safe 
therapeutic approach.
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